The PE Ratio as of November 2025 (TTM) for Arena Pharmaceuticals, Inc. (ARNA) is -9.86

According to Arena Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -9.86. This represents a change of 33.24% compared to the average of -7.40 of the last 4 quarters.

Arena Pharmaceuticals, Inc. (ARNA) Historical PE Ratio (quarterly & annually)

How has ARNA PE Ratio performed in the past?

The mean historical PE Ratio of Arena Pharmaceuticals, Inc. over the last ten years is -20.58. The current -9.86 PE Ratio has changed 4.69% with respect to the historical average. Over the past ten years (40 quarters), ARNA's PE Ratio was at its highest in in the June 2014 quarter at 43.03. The PE Ratio was at its lowest in in the September 2012 quarter at -28.63.

Arena Pharmaceuticals, Inc. (ARNA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Arena Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Arena Pharmaceuticals, Inc. (ARNA) Average PE Ratio

How has ARNA PE Ratio performed in the past?

The current PE Ratio of Arena Pharmaceuticals, Inc. (ARNA) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Arena Pharmaceuticals, Inc. (ARNA) PE Ratio vs. Peers

How is ARNA’s PE Ratio compared to its peers?

Arena Pharmaceuticals, Inc.’s PE Ratio is greater than IVERIC bio, Inc. (-27.51), greater than Reata Pharmaceuticals, Inc. (-20.07), less than Abcam plc (578.45), greater than Roivant Sciences Ltd. (-38.57), less than Mirati Therapeutics, Inc. (-4.46), greater than Cerevel Therapeutics Holdings, Inc. (-16.83), less than Opthea Limited (-1.15), greater than SpringWorks Therapeutics, Inc. (-13.86), greater than R1 RCM Inc. (-219.65), greater than MorphoSys AG (-11.77),

Build a custom stock screener for Arena Pharmaceuticals, Inc. (ARNA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arena Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Arena Pharmaceuticals, Inc. (ARNA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Arena Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.